Midodrine Improves Chronic Hypotension in Hemodialysis Patients



      The effects of midodrine on chronic hypotension in hemodialysis (HD) patients have not been well investigated.


      We evaluated midodrine’s effect on autonomic function and hemodynamics in 12 HD patients who had chronic systolic blood pressure less than 100 mm Hg. Midodrine (5.0 mg) twice a day was given for 4 weeks. Another 12 age- and sex-matched HD patients with normotension were selected as a control group. Autonomic function tests included the heart-rate responses to the Valsalva maneuver and 30:15 ratio as well as supine and standing blood pressure (BP) and sustained hand-grip test. Hemodynamic changes included 24-hour blood pressure, cardiac output, total peripheral resistance (TPR), and plasma renin and aldosterone concentrations.


      Compared with the control subjects, HD patients with chronic hypotension had more severe autonomic dysfunction and significantly lower TPR. After 4 weeks of midodrine therapy, sympathetic function (orthostatic and hand-grip tests) improved in conjunction with significant increases in mean arterial pressure (MAP) (79.5±4.9 to 85.0±5.1 mm Hg, P<0.05) and TPR (768±37 versus 1097±72 dyne/sec/cm−5, P<0.01) despite no significant change in Valsalva ratio, 30:15 ratio, and cardiac output. MAP changes were positively correlated with TPR changes (r=0.82, P<0.001). Supine plasma renin activity was significantly increased. In addition, MAP during HD was also significantly increased during midodrine therapy.


      Midodrine improves chronic hypotension in HD patients by modulating autonomic function and its direct effects on peripheral vessels.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Daul A.E.
        • Wang X.L.
        • Michel M.C.
        Arterial hypotension in chronic hemodialyzed patients.
        Kidney Int. 1987; 32: 728-735
        • Tsai Y.T.
        • Lin S.H.
        • Lee G.C.
        Arteriovenous fistula using transposed basilic vein in chronic hypotensive hemodialysis patients.
        Clin Nephrol. 2002; 57: 376-380
        • Victor R.G.
        • Henrich W.L.
        Autonomic neuropathy and hemodynamic stability in end-stage renal disease patients.
        in: Henrich W.L. Williams & Wilkins, Baltimore1994: 196-208
        • Kersh E.S.
        • Kronfiell S.J.
        • Unger A.
        Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension.
        N Engl J Med. 1974; 290: 650-653
        • Moore T.J.
        • Lazarus J.M.
        • Hakim R.M.
        Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients.
        Kidney Int. 1989; 36: 696-701
        • Carretta R.
        • Fabris B.
        • Fischetti F.
        Peripheral adrenoceptors in hypotension of hemodialyzed uremic patients.
        Nephron. 1992; 62: 429-433
        • Davies B.
        • Bannester R.
        • Sever P.
        The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone.
        Br J Clin Pharmacol. 1979; 8: 253-260
        • Schirger A.
        • Sheps S.G.
        • Thomas J.E.
        Midodrine. a new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
        Mayo Clin Proc. 1981; 56: 429-433
        • Kaufmann H.
        • Brannan T.
        • Krakoff L.
        Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).
        Neurology. 1988; 38: 951-956
        • Jankovic J.
        • Gilden J.L.
        • Hiner B.C.
        Neurologic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
        Am J Med. 1993; 95: 38-48
        • Alappan R.
        • Cruz D.
        • Abu-alfa A.K.
        Treatment of severe intradialytic hypotension with the addition of high dialysate calcium concentration to midodrine and/or cool dialysate.
        Am J Kidney Dis. 2001; 37: 294-299
        • Hoeben H.
        • Abu-alfa A.K.
        • Mahnensmith R.
        Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine.
        Am J Kidney Dis. 2002; 39: 102-107
        • Cruz D.N.
        • Mahnensmith R.L.
        • Brickel H.M.
        Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up.
        Clin Nephrol. 1998; 50: 101-107
        • Lin Y.F.
        • Wang J.Y.
        • Shum A.Y.C.
        Role of plasma catecholamines, autonomic, and left ventricular function in normotensive and hypotension prone dialysis patients.
        ASAIO J. 1993; 39: 946-953
        • Malik S.
        • Winney R.J.
        • Ewing D.J.
        Chronic renal failure and cardiovascular autonomic function.
        Nephron. 1986; 43: 191-195
        • McLeod J.G.
        • Tuck R.R.
        Disorders of the autonomic nervous system (part 2): investigation and treatment.
        Ann Neurol. 1987; 21: 519-529
        • Miach P.J.
        • Dawborn J.K.
        • Louis W.J.
        Left ventricular function in uremia: echocardiographic assessment in patients on maintenance dialysis.
        Clin Nephrol. 1981; 15: 259-263
        • Lin S.H.
        • Chu P.
        • Yu F.C.
        Increased nitric oxide production in hypotensive haemodialysis patients.
        ASAIO J. 1996; 42: M895-M899
        • Sorensen S.S.
        • Danielsen H.
        • Jespersen B.
        Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone, and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
        Clin Nephrol. 1986; 26: 288-296
        • Rascher W.
        • Schomig A.
        • Kreye V.A.
        Diminished vascular response to noradrenaline in experimental chronic uremia.
        Kidney Int. 1982; 21: 20-27
        • Hui K.K.
        • Conolly M.E.
        Increased numbers of beta-receptors in orthostatic hypotension due to autonomic dysfunction.
        N Engl J Med. 1981; 304: 1473-1476
        • Imai Y.
        • Abe K.
        • Otsuka Y.
        Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic failure.
        Jpn Circ J. 1981; 45: 303-314
        • Tajiri M.
        A clinical study of persistent hypotension in patients on chronic hemodialysis.
        Jpn J Nephrol. 1993; 35: 223-231
        • Fang J.T.
        • Huang C.C.
        Midodrine hydrochloride in patients on hemodialysis with chronic hypotension.
        Ren Fail. 1996; 18: 253-260
        • Blowey D.L.
        • Balfe J.W.
        • Gupta I.
        Midodrine efficiacy and pharmacokinetics in a patient with recurrent intradialytic hypotension.
        Am J Kidney Dis. 1996; 28: 132-136
        • Montagnac R.
        • Clavel P.
        • Delhotal-Landes B.
        Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient.
        Clin Nephrol. 2001; 56: 162-168
        • Taylor A.A.
        Autonomic control of cardiovascular function: clinical evaluation in health and disease.
        J Clin Pharmacol. 1994; 34: 363-374
        • Zoccali C.
        • Ciccarelli M.
        • Mallamaci F.
        The role of endogenous opioids in the baroreflex dysfunction of dialysis patients.
        Nephrol Dial Transplant. 1985; 21: 190-194
        • Jimbo M.
        • Suzuki H.
        • Ichikawa M.
        Role of nitric oxide in regulation of baroreceptor reflex.
        J Auton Nerv Syst. 1994; 50: 209-219
        • Zanzinger J.
        • Czachurski J.
        • Seller H.
        Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide.
        Am J Physiol. 1995; 268: R958-R962